Arakane F, Sugawara T, Nishino H, Liu Z, Holt J A, Pain D, Stocco D M, Miller W L, Strauss J F
Center for Research on Reproduction and Women's Health, University of Pennsylvania Medical Center, Philadelphia 19104, USA.
Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13731-6. doi: 10.1073/pnas.93.24.13731.
Steroidogenic acute regulatory protein (StAR) plays a critical role in steroid hormone biosynthesis, presumably by facilitating the delivery of cholesterol to P450scc in the inner mitochondrial membranes. StAR is synthesized as a 37-kDa preprotein that is processed to a 30-kDa mature form by cleavage of an N-terminal mitochondrial import sequence. To identify structural features required for StAR biological activity, we mutated the human StAR cDNA, including the deletion of N- and C-terminal sequences, and examined the ability of the mutants to promote steroidogenesis and enter the mitochondria of transfected COS-1 cells. Deletion of up to 62 residues from the N terminus (N-62) did not significantly affect steroidogenesis-enhancing activity. The N-terminal deletion mutants were associated with mitochondria-enriched fractions, but import and processing were progressively impaired with increasing length of the deletion. Immunogold electron microscopy and in vitro import assays showed that the active N-62 mutant was not imported into the mitochondria. Removal of the 28 C-terminal amino acids (C-28) inactivated StAR. Deletion of the C-terminal 10 amino acids (C-10) reduced steroidogenic activity by 53%, while truncation of the last 4 amino acids had no effect. The C-28 mutant StAR was not efficiently imported into mitochondria or processed, whereas some of the C-10 mutant was processed, indicating that import had occurred. We conclude that in the COS-1 cell system used, StAR does not need to enter into mitochondria to stimulate steroidogenesis and that residues in the C terminus are essential for steroidogenesis-enhancing activity. These findings imply that StAR acts via C-terminal domains on the outside of the mitochondria.
类固醇生成急性调节蛋白(StAR)在类固醇激素生物合成中起关键作用,可能是通过促进胆固醇转运至线粒体内膜中的细胞色素P450胆固醇侧链裂解酶(P450scc)。StAR最初合成时是一种37 kDa的前体蛋白,通过切割N端线粒体导入序列加工成30 kDa的成熟形式。为了确定StAR生物活性所需的结构特征,我们对人StAR cDNA进行了突变,包括删除N端和C端序列,并检测突变体促进类固醇生成以及进入转染的COS-1细胞线粒体的能力。从N端删除多达62个残基(N-62)对类固醇生成增强活性没有显著影响。N端缺失突变体与富含线粒体的组分相关,但随着缺失长度增加,导入和加工逐渐受损。免疫金电子显微镜和体外导入实验表明,有活性的N-62突变体未导入线粒体。去除28个C端氨基酸(C-28)使StAR失活。删除C端10个氨基酸(C-10)使类固醇生成活性降低53%,而截短最后4个氨基酸则没有影响。C-28突变体StAR不能有效地导入线粒体或进行加工,而部分C-!0突变体可以加工,表明发生了导入。我们得出结论,在所用的COS-1细胞系统中,StAR不需要进入线粒体来刺激类固醇生成,并且C端残基对于增强类固醇生成活性至关重要。这些发现表明,StAR通过线粒体外的C端结构域发挥作用。